News
4h
Dog Club on MSNDogs May Soon Live Longer Thanks to Breakthrough DrugEver wish that you could make your dog's life longer? While crossing the rainbow bridge is part of a dog's short life, ...
4h
Everyday Health on MSNTaking Too Many Supplements? Here's How to Tell, and Why It Can Be RiskySupplements, when approved by your doctor, may help you meet your nutritional needs. But there are potential health risks to ...
LIKMEZ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL re-launched and commercial sales ongoing Five U.S. government proposals submitted, totalling up to US$125 million HALIFAX, Nova Scotia ...
VANQUISH-1 and VANQUISH-2 Studies to Evaluate Subcutaneous VK2735 in Obese Adults with and without Type 2 Diabetes ...
Viking Therapeutics initiates VANQUISH phase 3 obesity clinical programme with GLP-1/GIP agonist VK2735: San Diego Thursday, June 26, 2025, 10:00 Hrs [IST] Viking Therapeutics, In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results